Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Phoebe Gauthier"'
Autor:
Emily Hichborn, Avery Turner, Sarah Moore, Phoebe Gauthier, Kathleen Bell, LaTrice Montgomery, Jesse Boggis, Chantal Lambert-Harris, Elizabeth Saunders, Jesse Dallery, Bethany McLeman, Lisa Marsch
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e50748 (2024)
BackgroundAlthough tobacco use has significantly declined in the general population, traditional tobacco use treatment uptake and success rates remain disproportionately low among people who identify as African American/Black, Hispanic/Latina/o, and
Externí odkaz:
https://doaj.org/article/8487559498094e47af7627e15894554f
Autor:
Bethany McLeman, Phoebe Gauthier, Laurie S. Lester, Felicity Homsted, Vernon Gardner, Sarah K. Moore, Paul J. Joudrey, Lisa Saldana, Gerald Cochran, Jacklyn P. Harris, Kathryn Hefner, Edward Chongsi, Kimberly Kramer, Ashley Vena, Rebecca A. Ottesen, Tess Gallant, Jesse S. Boggis, Deepika Rao, Marjorie Page, Nicholas Cox, Michelle Iandiorio, Ekow Ambaah, Udi Ghitza, David A. Fiellin, Lisa A. Marsch
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-13 (2024)
Abstract Background Pharmacists remain an underutilized resource in the treatment of opioid use disorder (OUD). Although studies have engaged pharmacists in dispensing medications for OUD (MOUD), few studies have evaluated collaborative care models i
Externí odkaz:
https://doaj.org/article/164c9bf7b10a421f9593acdd1b5a4426
Autor:
Ryan P. McCormack, John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, E. Jennifer Edelman, Sarah Farkas, Abigail G. Matthews, Caroline Mulatya, Dagmar Salazar, Jeremy Wolff, Randolph Knight, William Goodman, Kathryn Hawk
Publikováno v:
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-14 (2021)
Abstract Background For many reasons, the emergency department (ED) is a critical venue to initiate OUD interventions. The prevailing culture of the ED has been that substance use disorders are non-emergent conditions better addressed outside the ED
Externí odkaz:
https://doaj.org/article/687b3203f5e24aff9e76b8830f29c202
Autor:
Ryan P. McCormack, John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, E. Jennifer Edelman, Sarah Farkas, Abigail G. Matthews, Caroline Mulatya, Dagmar Salazar, Jeremy Wolff, Randolph Knight, William Goodman, Joseph Williams, Kathryn Hawk
Publikováno v:
Annals of Emergency Medicine.
Autor:
Sarah Farkas, John Rotrosen, Ryan P. McCormack, Dagmar Salazar, E. Jennifer Edelman, Phoebe Gauthier, David A. Fiellin, David Liu, Patricia Novo, Abigail G. Matthews, Jeremy Wolff, Gail D'Onofrio, Lisa A. Marsch, Caroline Mulatya, William Goodman, Kathryn Hawk, Randolph Knight
Publikováno v:
Addiction Science & Clinical Practice
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-14 (2021)
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-14 (2021)
Background For many reasons, the emergency department (ED) is a critical venue to initiate OUD interventions. The prevailing culture of the ED has been that substance use disorders are non-emergent conditions better addressed outside the ED where res
Autor:
Kathryn, Hawk, Ryan, McCormack, E Jennifer, Edelman, Edouard, Coupet, Nicolle, Toledo, Phoebe, Gauthier, John, Rotrosen, Marek, Chawarski, Shara, Martel, Patricia, Owens, Michael V, Pantalon, Patrick, O'Connor, Lauren K, Whiteside, Ethan, Cowan, Lynne D, Richardson, Michael S, Lyons, Richard, Rothman, Lisa, Marsch, David A, Fiellin, Gail, D'Onofrio
Publikováno v:
JAMA Network Open
This qualitative study assesses the experiences and perspectives of individuals with untreated opioid use disorder seen in emergency departments (EDs) in 5 regions of the US.
Key Points Question What are the experiences and perspectives regardin
Key Points Question What are the experiences and perspectives regardin
Publikováno v:
Journal of Substance Abuse Treatment. 122:108183
Background The National Drug Abuse Treatment Clinical Trials Network (CTN) multisite comparative-effectiveness study (“X:BOT”) by Lee et al. (2018) found that, once initiated, extended-release naltrexone (XR-NTX) is as similarly safe and effectiv
Autor:
R. Knight, Gail D'Onofrio, Lisa A. Marsch, Ryan P. McCormack, Phoebe Gauthier, E.J. E. Edelman, Patricia Novo, David A. Fiellin, Kathryn Hawk, John Rotrosen, W. Goodman
Publikováno v:
Annals of Emergency Medicine. 74:S62-S63
Autor:
Paul Schkolnik, Dikla Shmueli-Blumberg, Abigail G. Matthews, Genie L. Bailey, John Rotrosen, Dagmar Salazar, Jacquie King, Geetha Subramaniam, K Michelle Peavy, Candace C. Hodgkins, Patricia Novo, Snehal Bhatt, Sarah Farkas, David Liu, Joshua D. Lee, Robert Lindblad, Jeanine May, Marc Fishman, Stephen Ross, Edward V. Nunes, Phoebe Gauthier, Ken Bachrach, D. Stablein
Extended-release naltrexone (XR-NTX), an opioid antagonist, and sublingual buprenorphine-naloxone (BUP-NX), a partial opioid agonist, are pharmacologically and conceptually distinct interventions to prevent opioid relapse. We aimed to estimate the di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b357ed13be697fb7cd4f3d4ecd6021a7
https://europepmc.org/articles/PMC5806119/
https://europepmc.org/articles/PMC5806119/
Autor:
Michael P. Bogenschutz, Mei-Chen Hu, Edward V. Nunes, Raul N. Mandler, Ryan P. McCormack, Gail D'Onofrio, David A. Thompson, Martina Pavlicova, Lauren Moy, Phoebe Gauthier, Bridget McClure, John Rotrosen
Publikováno v:
Addiction Science & Clinical Practice